Bone Biologics Corporation (BBLG)
NASDAQ: BBLG · Real-Time Price · USD
2.310
-0.540 (-18.95%)
At close: Sep 5, 2025, 4:00 PM
2.280
-0.030 (-1.31%)
After-hours: Sep 5, 2025, 7:59 PM EDT
Bone Biologics Market Cap
Bone Biologics has a market cap or net worth of $4.15 million as of September 5, 2025. Its market cap has increased by 65.62% in one year.
Market Cap
4.15M
Enterprise Value
-2.49M
1-Year Change
65.62%
Ranking
Category
Stock Price
$2.31
Market Cap Chart
Since March 31, 2016, Bone Biologics's market cap has decreased from $155.72M to $4.15M, a decrease of -97.34%. That is a compound annual growth rate of -31.90%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 5, 2025 | 4.15M | 79.03% |
| Dec 31, 2024 | 2.32M | -4.06% |
| Dec 29, 2023 | 2.41M | -24.75% |
| Dec 30, 2022 | 3.21M | -91.19% |
| Dec 31, 2021 | 36.43M | -58.55% |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 23, 2016 | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 652.84B |
| Johnson & Johnson | 429.72B |
| AbbVie | 375.50B |
| UnitedHealth Group | 285.64B |
| AstraZeneca | 253.68B |
| Novartis AG | 252.55B |
| Novo Nordisk | 244.67B |
| Abbott Laboratories | 231.38B |